U.S. Logistics Stock News

NasdaqGS:CAPR
NasdaqGS:CAPRBiotechs

Capricor Therapeutics (CAPR) Could Be 58% Undervalued Following FDA Focus And Index Removal

Capricor Therapeutics stock reacts to index removal and regulatory focus Capricor Therapeutics (CAPR) has come into focus after being removed from several Russell indices, just as investors track upcoming U.S. FDA advisory committee discussions on Deramiocel, its Duchenne muscular dystrophy cell therapy candidate. See our latest analysis for Capricor Therapeutics. Capricor Therapeutics shares have come under pressure in the short term, with the stock down 21.82% over seven days and 28.15%...
NYSE:NCLH
NYSE:NCLHHospitality

Is Norwegian Cruise Line Holdings (NCLH) Stock Cheap Or Reasonable Today?

Norwegian Cruise Line Holdings stock trades around US$20.67 after a mixed stretch for shareholders, with the market still pricing it as undervalued on earnings multiples even though the broader valuation checks only point to a partial bargain. The share price has fallen about 24% over the past 5 years, which means long term holders have not yet seen a recovery that clearly validates the current valuation. Improved sentiment around fuel costs and ongoing investment in its product offering can...
NYSE:ABR
NYSE:ABRMortgage REITs

Arbor Realty Trust (ABR) After Its Note Deal Faces A Fresh Valuation Test

Arbor Realty Trust (ABR) has just completed a private offering of US$325 million in 6.25% Convertible Senior Notes due 2029, a funding move that immediately reshaped how the stock is being discussed. See our latest analysis for Arbor Realty Trust. Arbor Realty Trust's recent capital moves come after a tough stretch for the stock. The latest share price is US$5.36, with a 7 day share price return of 5.30%, but a year to date share price return down 32.58% and a 1 year total shareholder return...
NasdaqGM:HRMY
NasdaqGM:HRMYPharmaceuticals

Is Harmony Biosciences Holdings (HRMY) A Bargain After Its Neuroscience Pipeline Push?

Recent coverage of Harmony Biosciences Holdings (HRMY) focuses on its effort to broaden beyond Wakix, with pitolisant studies in idiopathic hypersomnia and rare diseases, along with new neuroscience drug candidates that are drawing fresh investor attention. See our latest analysis for Harmony Biosciences Holdings. At a share price of US$36.00, Harmony Biosciences Holdings has seen a 30-day share price return of 13.17% and a 90-day share price return of 29.78%. Its 1-year total shareholder...
NYSE:ACEL
NYSE:ACELHospitality

Accel Entertainment (ACEL) After Russell 2000 Exit Has Undervaluation Back In Focus

Index removal puts Accel Entertainment back in focus Accel Entertainment (ACEL) was recently removed from the Russell 2000 Dynamic Index, an event that can influence institutional ownership patterns, index tracking fund flows, and short term trading activity around the stock. See our latest analysis for Accel Entertainment. Against that backdrop, Accel Entertainment’s recent share price moves have been mixed, with a 1-day share price return of 1.27% but a 7-day share price return that...
NasdaqGS:PANW
NasdaqGS:PANWSoftware

Palo Alto Networks (PANW) Wins AI Backing And Upgrades, Is The Stock Fully Priced?

Investor sentiment around Palo Alto Networks (PANW) has shifted higher after strong Q3 revenue and annual recurring revenue figures, a wave of analyst upgrades, and new AI-focused collaborations with IBM and Red Hat. See our latest analysis for Palo Alto Networks. Palo Alto Networks’ recent AI-focused partnerships with IBM, Red Hat and Wipro have coincided with strong momentum in the stock, with a 7-day share price return of 23.41%, a 90-day share price return of 115.70% and a 5-year total...
NYSE:PINS
NYSE:PINSInteractive Media and Services

Pinterest (PINS) Stock Looks Discounted After A 72% Fall Yet Rich On Earnings

Pinterest has seen its share price fall 71.8% over the past five years, and the latest valuation checks suggest the stock still screens as expensive rather than a clear bargain despite that pullback. Over the past 5 years, Pinterest shareholders have seen the stock decline 71.8%, which puts more focus on whether today’s price now reflects the company’s risks and opportunities. On the upside, TD Cowen points to the potential for Pinterest’s Performance+ advertising solutions to support future...
NYSE:BANC
NYSE:BANCBanks

3 Financial Stocks That Could Benefit If Interest Rates Stay Higher Longer

Rising rate expectations and sticky inflation are reshaping how investors think about financial stocks, as higher yields can alter funding costs, loan demand, and the appeal of insurance reserves. With the Federal Reserve signaling that policy could stay tighter for longer, some banks and insurers may find this backdrop supportive, while others could face more pressure. This article looks at three large, well regarded financial stocks from our screener that appear positively exposed to the...
NYSE:GHC
NYSE:GHCConsumer Services

Is Graham Holdings (GHC) Fairly Valued As Its Stock Extends Strong Returns?

Graham Holdings stock performance and recent context Graham Holdings (GHC) has drawn investor attention after a recent move in its share price, with the stock last closing at $1,169.91 and showing mixed short term returns across the past week and month. Over the past month, Graham Holdings has returned about 5%, while the past 3 months show a gain of roughly 10%. Year to date, the stock is up around 8%, and the 1 year total return stands near 24%. See our latest analysis for Graham...
NYSE:TEL
NYSE:TELElectronic

TE Connectivity (TEL) Stock Trades Near Fair Value Despite Its 59% Run

TE Connectivity stock has delivered a 59.3% return over the past five years, and at around US$201 per share the key question now is whether that performance is already fully reflected in the price or if valuation checks still leave some room on the table. Over the last five years, TE Connectivity has returned 59.3%, which puts the recent pullback this year into context for longer term holders. Record orders tied to AI infrastructure, electric vehicles and grid upgrades can support...
NasdaqGS:PDD
NasdaqGS:PDDMultiline Retail

PDD (PDD) Stock Looks Cheap On Value But Weak On Returns

PDD Holdings has seen its share price fall 28.7% year to date, yet its valuation checks still lean cheap, creating a tension between weak recent returns and what the numbers imply about value. The stock is down 28.7% year to date, which means recent sentiment has been soft even before considering the latest analyst downgrades. Heavy investment in its e-commerce ecosystem can support future revenue potential, but for now it is weighing on margins and has raised questions about how quickly...
NYSE:KR
NYSE:KRConsumer Retailing

Kroger (KR) Stock Looks Fairly Priced As Its Giant Eagle Deal Looms

Kroger stock has fallen back over the past year, yet over five years it is still showing a gain of 66.2%, and the current valuation checks point to a picture that looks roughly in line with the market rather than clearly cheap or clearly expensive. Kroger has returned 66.2% over the past five years, which suggests long term holders have still been rewarded despite the recent pullback. The planned Giant Eagle acquisition and push into higher margin areas, such as retail media, can support...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

Is CoreWeave (CRWV) Ready for Meta’s Compute Competition After Launching ARIA and Expanding in Europe?

In late June 2026, CoreWeave launched ARIA, an AI research agent embedded in Weights & Biases that automates experiment analysis and model iteration, while expanding its AI cloud footprint in Europe through new renewable-powered data center capacity and a multi-exabyte storage deal with Backblaze. At the same time, reports that Meta Platforms plans to sell its own excess AI compute capacity have raised fresh questions about CoreWeave’s dependence on major customers and its position in an...
NasdaqGS:AMBA
NasdaqGS:AMBASemiconductor

Is Ambarella (AMBA) Reasonable After Its 40% Run Or Stretched?

After a sharp 40.2% move over the past week, Ambarella now screens as only roughly in line with its Discounted Cash Flow (DCF) intrinsic value estimate, while the broader valuation checks and market multiples lean toward the stock looking expensive rather than cheap. Ambarella's 40.2% gain in the past week has quickly reset expectations, which can reduce the margin of safety for new money going into the stock. Investor enthusiasm around Ambarella's growth in AI focused chips and automotive...
NYSE:MS
NYSE:MSCapital Markets

Morgan Stanley (MS) Wins Preliminary Approval For A Digital Asset Trust Bank

Morgan Stanley (NYSE:MS) has received conditional approval from the Office of the Comptroller of the Currency for a national digital-asset trust bank. The new federally supervised subsidiary is expected to provide digital-asset custody and trading services to clients. The approval marks a new step for the company beyond its existing wealth management and capital markets offerings. Morgan Stanley is already a major US bank in wealth management, investment banking, and trading, and this move...
NasdaqGS:CBRS
NasdaqGS:CBRSSemiconductor

Is Cerebras Systems (CBRS) Still Undervalued As Q1 Results And OpenAI Deal Lift Confidence?

Cerebras Systems (CBRS) is back in focus after its Q1 2026 earnings call on June 23, where the AI infrastructure company reported higher revenue, a smaller net loss, and fresh scrutiny of its valuation. See our latest analysis for Cerebras Systems. Cerebras Systems’ share price has rebounded sharply in the past week, with a 7 day share price return of 21.4% and a 30 day share price return of 3.75%. However, the year to date share price return is still down 28.87%, highlighting how recent...
NYSE:STE
NYSE:STEMedical Equipment

STERIS (STE) Stock Looks Below Fair Value Following Its 15% Slide

Steris stock has declined 15.1% year to date, yet the current Discounted Cash Flow (DCF) intrinsic value estimate points to about 13.2% potential upside from the latest closing price of US$212.30, while the broader valuation checks paint a less generous picture. Steris is down 15.1% year to date, which puts more focus on whether the current price already reflects cautious expectations for the business. For a company built around recurring healthcare equipment and services, expectations for...